Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

As companies invest billions in artificial intelligence, employees are being asked to prove they’re using it. AI adoption at work Despite quick AI growth, most employees aren't using it daily yet. A ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

Moderna’s latest flu vaccine, based on similar mRNA technology integrated in its COVID-19 shot, displayed optimistic outcomes ...

An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Moderna’s mRNA flu shot outperforms existing vaccines in Phase 3 trial, showing over 26% greater efficacy—paving the way for ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Marcos Leonardo scored twice, including a follow-up game-winner at the left post in extra time to lead Al Hilal to a shocking ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.